Dr. Dobuler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 Division St
Derby, CT 06418Phone+1 203-732-7573Fax+1 203-732-7418
Education & Training
Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1980 - 1981- Yale-New Haven Medical CenterResidency, Internal Medicine, 1976 - 1979
Yale School of MedicineClass of 1976
Certifications & Licensure
CT State Medical License 1978 - 2025
GA State Medical License 2022 - 2025
MO State Medical License 2024 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
Publications & Presentations
PubMed
- 24 citationsSulfasalazine-induced pulmonary diseaseRichard H. Moseley, Kenneth W. Barwick, Kenneth J. Dobuler, Vincent A. DeLuca
Digestive Diseases and Sciences. 1985-09-01 - 40 citationsPulmonary endothelial dysfunction in the presence or absence of interstitial injury induced by intratracheally injected bleomycin in rabbits.John D. Catravas, John S. Lazo, Kenneth J. Dobuler, Mills Lr, C N Gillis
The American Review of Respiratory Disease. 1983-10-01 - 8 citationsProlonged reduction in serum angiotensin converting enzyme activity after treatment of rabbits with bleomycin.John S. Lazo, John D. Catravas, Kenneth J. Dobuler, C. Norman Gillis
Toxicology and Applied Pharmacology. 1983-06-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
